SCHEMBL2363540

SCHEMBL2363540

NC=CCN1CCCCC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 1/20 0.36
HRH3 Q9Y5N1 4/20 0.36
CHRNB2 P17787 1/20 0.35
CHRNB4 P30926 1/20 0.35
CHRNA3 P32297 1/20 0.35
CHRNA4 P43681 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.33
SIGMAR1 Q99720 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
LMNA P02545 2/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
CARM1 Q86X55 1/20 0.32
PRMT6 Q96LA8 1/20 0.32
PRMT8 Q9NR22 1/20 0.32
CHRM5 P08912 1/20 0.32
ADRA2C P18825 1/20 0.32
ALDH1A1 P00352 1/20 0.31
MAPT P10636 1/20 0.31
ANPEP P15144 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1169814 0.97
SCHEMBL6097541 0.97
SCHEMBL1464365 0.86 ALOX15 (0.32)
SCHEMBL1464937 0.86 ALOX15 (0.32)
SCHEMBL5140694 0.86
SCHEMBL23872301 0.83 HRH3 (0.43) LTA4HHRH3CHRNB2CHRNB4CHRNA3
SCHEMBL10748748 0.83 HRH3 (0.43) LTA4HHRH3CHRNB2CHRNB4CHRNA3
SCHEMBL7227482 0.83 HRH3 (0.43) LTA4HHRH3CHRNB2CHRNB4CHRNA3
SCHEMBL23872300 0.80 LTA4H (0.42) LTA4HHRH3CHRNB2CHRNB4CHRNA3
SCHEMBL175418 0.75 POLB (0.35) HRH3SIGMAR1MEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 120 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240074437-A1 SURFACE ANTIMICROBIAL TREATMENTS Crossing S.r.l. (IT) 2024-03-07 US claimed
EP-4258879-A1 SURFACE ANTIMICROBIAL TREATMENTS Crossing S.r.l. (IT) 2023-10-18 EP claimed
WO-2022123441-A1 SURFACE ANTIMICROBIAL TREATMENTS Crossing S.r.l. (IT) 2022-06-16 WO claimed
EP-3079728-A1 PHOTOACOUSTIC IMAGING CONTRAST AGENT Agency For Science, Technology And Research (SG) 2016-10-19 EP claimed
US-20160287727-A1 PHOTOACOUSTIC IMAGING CONTRAST AGENT AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2016-10-06 US claimed
US-20160131957-A1 ELECTROPHORETIC DISPLAY HAVING CHARGED FLUORESCENT DENDRIMER PARTICLES EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) 2016-05-12 US claimed
WO-2015088444-A1 PHOTOACOUSTIC IMAGING CONTRAST AGENT AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2015-06-18 WO claimed
WO-2014209300-A1 ELECTROPHORETIC DISPLAYS HAVING CHARGED FLUORESCENT DENDRIMER PARTICLES EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) 2014-12-31 WO claimed
US-6111056-A Cyclic amine based polymers and process for their production BASF AKTIENGESELLSCHAFT (DE) 2000-08-29 US claimed
US-4054731-A Process for curing liquid chloroprene polymer containing xanthate active terminal groups using polyfunctional amines DENKI KAGAKU KOGYO KABUSHIKI KAISHA (JA) 1977-10-18 US claimed
JP-54071196-A None JP disclosed
JP-3154624-A None JP disclosed
JP-55134602-A None JP disclosed
CN-114874709-A Polyurethane protective film with low film tearing voltage 惠州市浩明科技股份有限公司 2022-08-09 CN disclosed
CN-104073182-B Antistatic adhering piece and optical film 日东电工株式会社 2019-08-23 CN disclosed
US-4186014-A WATER-SOLUBLE QUATERNIZED POLYURETHANE OF POLYUREA AGFA-GEVAERT AKTIENGESELLSCHAFT (DE) 1980-01-29 US disclosed
JP-S5471196-A PREPARATION OF MODIFIED AROMATIC POLYAMIDE ASAHI CHEM IND CO LTD 1979-06-07 JP disclosed
US-4138292-A ENZYMES OR MICROORGANISMS IN A SULFATED POLYSACCHARIDE GEL TANABE SEIYAKU CO., LTD. (JP) 1979-02-06 US disclosed
US-4082755-A NEUROLEPTIC JANSSEN PHARMACEUTICA N.V. (BE) 1978-04-04 US disclosed
US-4054731-A Process for curing liquid chloroprene polymer containing xanthate active terminal groups using polyfunctional amines DENKI KAGAKU KOGYO KABUSHIKI KAISHA (JA) 1977-10-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240074437-A1 SURFACE ANTIMICROBIAL TREATMENTS CUTA, ETF1, SFN LTA4H 3796/4885HRH3 1368/4885CHRNB2 4821/4885
US-20160287727-A1 PHOTOACOUSTIC IMAGING CONTRAST AGENT PHOSPHO1, TAGLN2, FABP7 LTA4H 602/4885HRH3 1971/4885CHRNB2 3358/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.